The relationship between prolactin levels, sleep disorders and the effectiveness of glycaemia correction in patients with hypertension and type 2 diabetes mellitus
Journal Title: Український терапевтичний журнал - Year 2019, Vol 0, Issue 3
Abstract
Objective — to assess sleep disorders in patients with hypertension and type 2 diabetes mellitus and to establish the role of prolactin in the formation of these changes. Materials and methods. The study included 63 patients with hypertension and type 2 diabetes mellitus. All patients were evaluated for sleep disorders using the Epworth Daytime Sleepiness Scale and the International Classification of Sleep Disorders Scale (International Academy of Sleep Disorders, Issue 3, 2014). The levels of plasma lipids, blood glucose level, glycosylated hemoglobin as well as anthropometric parameters were measured in all patients. Prolactin was determined using immunosorbent analysis using fixed enzymes (principle conjugated by ELISA peroxidase) on an Immunochem-2100 analyzer. Results and discussion. Patients were divided into four groups depending on the prolactin level according to quartiles. Group 1 included 14 patients, with prolactin levels from 97.1 to 211.5; group 2 included 18 patients with prolactin levels from 221.6 to 271.2; group 3 included 19 patients with prolactin levels from 271.3 to 422.8, and group 4 consisted of 11 patients with prolactin levels of 422.9—563.5. It has been established that patients with low prolactin level (groups I—II) were more likely to experience early awakenings in comparison with patients with high level of prolactin (groups III—IV). Patients with low prolactin level had significantly higher Epworth score. The strong inverse correlation has been found between prolactin levels and metformin dose (Pearson correlation coefficient –0.427, p = 0.001). Conclusions. Patients with type 2 diabetes mellitus, hypertension, and sleep disorders (high score on the Epworth scale and early awakenings) had significantly lower prolactin levels than patients without sleep disorders.
Authors and Affiliations
O. О. Buriakovska, G. S. Isayeva
Experience of anticoagulant therapy in patients with pulmonary embolism
Objective — to perform the comparative analysis of the administration of two anticoagulants (dabigatran and warfarin) for the treatment of pulmonary embolism. The demographic and clinical features of the patients in bot...
Effects of actovegin on the treatment efficacy of patients with gastroesophageal reflux disease with concomitant bronchial asthma
Objective — to study the actovegin effects on the clinical course of comorbid pathology, the quality of life of patients and the state of oxidative stress, that is, the level of aggression and protection factors, against...
Obesity, diabetes mellitus and oncopathology: epidemiological and pathogenetic aspects
The review article is devoted to discussion of epidemiological and pathogenetic aspects of relationship between obesity, diabetes mellitus (DM) and oncopathology as well as to discussion of the data about the influence o...
The correlations between the clinical and anamnestic characteristics and biochemical parameters of bone tissue metabolism at the comorbidity of chronic pancreatitis and arterial hypertension
Objective — to establish the presence of correlations between the clinical and anamnestic characteristics of patients and biochemical indicators of bone tissue metabolism, as well as the presence of fractures in patients...
Macrophage migration inhibitory factor and acute myocardial infarction
Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine involved in the development of many acute and chronic inflammatory diseases, including cardiovascular diseases. A link between MIF a...